Skip to main content
. 2021 Sep 13;22(5):783. doi: 10.3892/ol.2021.13044

Figure 2.

Figure 2.

Kaplan-Meier estimates of (A) progression-free survival and (B) overall survival based on presence or absence of grade 3 or 4 neutropenia within the first cycle of treatment. CI, confidence interval.